Wu Shujing, Xu Yu, Zheng Ruizhi, Lu Jieli, Li Mian, Chen Li, Huo Yanan, Xu Min, Wang Tiange, Zhao Zhiyun, Wang Shuangyuan, Lin Hong, Dai Meng, Zhang Di, Niu Jingya, Qin Guijun, Yan Li, Wan Qin, Chen Lulu, Shi Lixin, Hu Ruying, Tang Xulei, Su Qing, Yu Xuefeng, Qin Yingfen, Chen Gang, Gao Zhengnan, Wang Guixia, Shen Feixia, Luo Zuojie, Chen Yuhong, Zhang Yinfei, Liu Chao, Wang Youmin, Wu Shengli, Yang Tao, Li Qiang, Mu Yiming, Zhao Jiajun, Bi Yufang, Wang Weiqing, Ning Guang
Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Lancet Reg Health West Pac. 2022 Jan 8;20:100350. doi: 10.1016/j.lanwpc.2021.100350. eCollection 2022 Mar.
The updated definition of hypertension by the American College of Cardiology (ACC) and the American Heart Association (AHA) is an important paradigm shift and has lead to extensive discussion. We aimed to examine the association between the updated blood pressure (BP) categories and the risk of cardiovascular diseases (CVDs) with potential modifications from other cardiovascular health metrics (CVHMs).
This prospective study included 91,204 participants ≥40 years recruited from 20 community sites across mainland China. Participants were followed up during 2010-2016 for CVD events including nonfatal myocardial infarction, stroke, heart failure, and cardiovascular death. BP categories were defined according to the 2017 ACC/AHA guideline and CVHMs included smoking, physical activity, diet, body-mass index, total cholesterol, and fasting glucose.
Overall, 1,985 major CVD events occurred during a mean follow-up of 3.7 years. Having more ideal CVHMs significantly reduced the risk of CVD events in both stage 1 and stage 2 hypertension. Compared with participants without hypertension, participants having ≥4 ideal CVHMs were no longer associated with an increased CVD risk in stage 1 hypertension (HR=1·04; 95% CI=0·83-1·31), but less so in stage 2 hypertension (HR=1·90, 95% CI=1·70-2·13). Such pattern of association was more evident in participants aged <60 years ( for interaction <0·05).
Stage 1 hypertension defined by the ACC/AHA identifies individuals at increased CVD risk, which can be attenuated by achieving more preferable cardiovascular health, especially in adults aged <60 years.
美国心脏病学会(ACC)和美国心脏协会(AHA)对高血压的更新定义是一项重要的范式转变,并引发了广泛讨论。我们旨在研究更新后的血压类别与心血管疾病(CVD)风险之间的关联,以及其他心血管健康指标(CVHM)的潜在修正作用。
这项前瞻性研究纳入了来自中国大陆20个社区地点的91204名年龄≥40岁的参与者。在2010年至2016年期间对参与者进行随访,观察CVD事件,包括非致命性心肌梗死、中风、心力衰竭和心血管死亡。血压类别根据2017年ACC/AHA指南定义,CVHM包括吸烟、身体活动、饮食、体重指数、总胆固醇和空腹血糖。
总体而言,在平均3.7年的随访期间发生了1985例主要CVD事件。拥有更多理想的CVHM可显著降低1期和2期高血压患者发生CVD事件的风险。与无高血压的参与者相比,拥有≥4项理想CVHM的参与者在1期高血压中不再与CVD风险增加相关(HR=1.04;95%CI=0.83-1.31),但在2期高血压中相关性较小(HR=1.90,95%CI=1.70-2.13)。这种关联模式在年龄<60岁的参与者中更为明显(交互作用P<0.05)。
ACC/AHA定义的1期高血压识别出CVD风险增加的个体,通过实现更优的心血管健康状况可降低这种风险,尤其是在年龄<60岁的成年人中。